Vontobel Holding’s Perspective Therapeutics CATX Stock Holding History

Vontobel Holding’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.9K	Buy	22,000 +4,000	+22%	+$15.1K	﹤0.01%	1427
2026 Q1	$75.1K	Sell	18,000 -7,000	-28%	-$29.6K	﹤0.01%	1164
2025 Q4	$68.6K	Buy	25,000 +5,000	+25%	+$14.3K	﹤0.01%	1389
2025 Q3	$69K	Hold	20,000	–	–	﹤0.01%	1311
2025 Q2	$68.8K	Hold	20,000	–	–	﹤0.01%	1220
2025 Q1	$42.6K	Buy	20,000 +4,000	+25%	+$12K	﹤0.01%	1066
2024 Q4	$51K	Buy	+16,000	New	+$131K	﹤0.01%	1070
2024 Q2	–	Sell	-8,000	Closed	-$95.2K	–	1088
2024 Q1	$95.2K	Buy	+8,000	New	+$68.2K	﹤0.01%	1029

Other funds holding CATX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Vontobel Holding's CATX Position: Q2 2026 in Review

Vontobel Holding increased its Perspective Therapeutics (CATX) stake by 22% in Q2 2026, buying an estimated $15.1K and bringing the position to 22,000 shares worth $74.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

Vontobel Holding first reported a position in CATX in Q1 2024 and has held it in 8 quarters since. The position peaked at $95.2K in Q1 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

Vontobel Holding held 22,000 shares of Perspective Therapeutics worth $74.9K as of Q2 2026.
Vontobel Holding bought 4,000 Perspective Therapeutics shares in Q2 2026, an estimated $15.1K.
Perspective Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1427 holding.
Vontobel Holding first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 8 quarters since.
Vontobel Holding's Perspective Therapeutics position peaked at $95.2K in Q1 2024.
131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.